|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues | ||||
| Expenses | ||||
| Operating costs | ||||
| Professional, consulting and management fees | ||||
| Foreign exchange gain (loss) | ||||
| Other general and administrative expenses | ||||
| Share-based payments | ||||
| Finance costs | ||||
| Interest income | ||||
| Technology start-up costs | ||||
| Recovery (write-down) of vanadium assets | ||||
| Exploration and evaluation costs | ||||
| Gain on disposal of interest in subsidiary | ||||
| Share of net loss from investment in associate | ||||
| Total Expenses | ||||
| Net loss before tax | ||||
| Income tax recovery | ||||
| Deferred income tax (expense) recovery | ||||
| Net loss | ||||
| Comprehensive loss attributable to: | ||||
| Owners of the Company | ||||
| Non-controlling interests | ||||
| Other comprehensive loss | ||||
| Items that subsequently will be reclassified to operations: | ||||
| Unrealized gain (loss) on foreign currency translation | ||||
| Comprehensive loss | ||||
| Other comprehensive loss | ||||
| Basic loss per Common Share | ||||
| Diluted loss per Common Share | ||||
| Weighted Average Number of Shares Outstanding (in 000's) | ||||
| - Basic | ||||
| - Diluted | ||||
| Net loss attributable to: | ||||
| Owners of the Company | ||||
| Non-controlling interests |
Loading...
